Crystal structures of active Src kinase domain complexes

被引:70
作者
Breitenlechner, CB
Kairies, NA
Honold, K
Scheiblich, S
Koll, H
Greiter, E
Koch, S
Schäfer, W
Huber, R
Engh, RA [1 ]
机构
[1] Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany
[2] Roche Diagnost GMBH, Pharma Res, D-82372 Penzberg, Germany
关键词
crystal structure; drug design; cell signalling; Src; protein kinase;
D O I
10.1016/j.jmb.2005.08.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
c-Src was the first proto-oncoprotein to be identified, and has become, the focus of many drug discovery programs. Src structures of a major inactive form have shown how the protein kinase is rigidified by several interdomain interactions; active configurations of Src are generated by release from this "assembled" or "bundled" form. Despite the importance of Src as a drug target, there is relatively little structural information available regarding the presumably more flexible active forms. Here we report three crystal structures of a dimeric active c-Src kinase domain, in an apo and two ligand complexed forms, with resolutions ranging from 2.9 angstrom to 1.95 angstrom. The structures show how the kinase domain, in the absence of the rigidifying interdomain interactions of the inactivation state, adopts a more open and flexible conformation. The ATP site inhibitor CGP77675 binds to the protein kinase with canonical hinge hydrogen bonds and also to the c-Src specific threonine 340. In contrast to purvalanol B binding in CDK2, purvalanol A binds in c-Src with a conformational change in a more open ATP pocket. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:222 / 231
页数:10
相关论文
共 49 条
  • [1] The specificities of protein kinase inhibitors: an update
    Bain, J
    McLauchlan, H
    Elliott, M
    Cohen, P
    [J]. BIOCHEMICAL JOURNAL, 2003, 371 : 199 - 204
  • [2] Structure and regulation of Src family kinases
    Boggon, TJ
    Eck, MJ
    [J]. ONCOGENE, 2004, 23 (48) : 7918 - 7927
  • [3] ACTIVATION OF PP60C-SRC PROTEIN-KINASE ACTIVITY IN HUMAN-COLON CARCINOMA
    BOLEN, JB
    VEILLETTE, A
    SCHWARTZ, AM
    DESEAU, V
    ROSEN, N
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) : 2251 - 2255
  • [4] Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity
    Brown, NR
    Noble, MEM
    Lawrie, AM
    Morris, MC
    Tunnah, P
    Divita, G
    Johnson, LN
    Endicott, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) : 8746 - 8756
  • [5] PP60C-SRC ACTIVATION IN HUMAN-COLON CARCINOMA
    CARTWRIGHT, CA
    KAMPS, MP
    MEISLER, AI
    PIPAS, JM
    ECKHART, W
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) : 2025 - 2033
  • [6] The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation
    Cowan-Jacob, SW
    Fendrich, G
    Manley, PW
    Jahnke, W
    Fabbro, D
    Liebetanz, J
    Meyer, T
    [J]. STRUCTURE, 2005, 13 (06) : 861 - 871
  • [7] COWANJACOB S, 2003, 226 ACS NAT M AM CHE
  • [8] DOMAIN MOVEMENTS IN PROTEIN-KINASES
    COX, S
    RADZIOANDZELM, E
    TAYLOR, SS
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 1994, 4 (06) : 893 - 901
  • [9] NUCLEOTIDE-SEQUENCE OF AN AVIAN-SARCOMA VIRUS ONCOGENE (SRC) AND PROPOSED AMINO-ACID-SEQUENCE FOR GENE-PRODUCT
    CZERNILOFSKY, AP
    LEVINSON, AD
    VARMUS, HE
    BISHOP, JM
    TISCHER, E
    GOODMAN, HM
    [J]. NATURE, 1980, 287 (5779) : 198 - 203
  • [10] CRYSTAL-STRUCTURE OF CYCLIN-DEPENDENT KINASE-2
    DEBONDT, HL
    ROSENBLATT, J
    JANCARIK, J
    JONES, HD
    MORGAN, DO
    KIM, SH
    [J]. NATURE, 1993, 363 (6430) : 595 - 602